The prognostic Value of Thyroid Hormone Levels in Immunotherapy-Treated Patients With Metastatic Urothelial Carcinoma.

Clinical genitourinary cancer(2023)

引用 0|浏览2
暂无评分
摘要
Thyroid hormone impairment, as measured by the fT3/fT4 ratio, is a strong prognostic factor in patients treated with immunotherapy for urothelial carcinoma.
更多
查看译文
关键词
Bladder carcinoma,fT3/fT4,Deiodination,Immune checkpoint inhibitors,Urothelial carcinoma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要